Related Experiment Video
Updated: Aug 6, 2026

09:35
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
Personalized Embryo Transfer Improves Live Birth Rates in Recurrent Implantation Failure: A Propensity Score-Matched
Yasuhiro Ohara1,2, Kurumi Abe3, Saki Saito3
1Department of Reproductive Medicine Reproduction Clinic Osaka Osaka Japan.
Reproductive Medicine and Biology
|July 23, 2026
Summary
Personalized embryo transfer (pET) guided by ERPeak significantly boosts live birth rates in patients with recurrent implantation failure (RIF) undergoing hormone replacement therapy or modified natural cycle frozen embryo transfer. The window of implantation (WOI) is dynamic and requires reevaluation in older patients.
Area of Science:
- Reproductive Medicine
- Embryology
- Infertility Research
Background:
- Recurrent implantation failure (RIF) poses a significant challenge in assisted reproductive technologies.
- Optimizing embryo transfer timing is crucial for successful pregnancy outcomes.
- The window of implantation (WOI) can vary between individuals and over time.
Purpose of the Study:
- To assess the clinical effectiveness of ERPeak-guided personalized embryo transfer (pET) for patients with and without RIF.
- To evaluate the stability of the window of implantation (WOI) over time.
- To compare pET with non-personalized embryo transfer (npET) in frozen embryo transfer (FET) cycles.
Main Methods:
- A prospective cohort study involving patients undergoing FET with good-quality embryos.
- Comparison of pET versus npET in hormone replacement therapy (HRT) cycles for RIF and non-RIF patients.
- Analysis of modified natural cycle (mNC) FET using inverse probability of treatment weighting (IPTW) and propensity score matching (PSM).
Main Results:
- In RIF patients, pET significantly increased live birth rates (LBR) (41.0% vs. 23.6%) and reduced miscarriage rates (17.4% vs. 36.2%) post-PSM.
- pET did not significantly improve LBR in non-RIF patients (35.8% vs. 25.4%).
- IPTW analysis showed higher LBR with pET in mNC-FET cycles (46.3% vs. 19.2%).
- WOI stability decreased significantly faster in patients aged 38 years and older.
Conclusions:
- ERPeak-guided pET enhances LBR in RIF patients undergoing HRT and mNC-FET.
- pET does not confer benefits for non-RIF patients.
- The WOI is dynamic, and its stability diminishes with age, necessitating reevaluation in older individuals.

